Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;52(1):244-50.
doi: 10.1128/JCM.01249-13. Epub 2013 Nov 6.

Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens

Affiliations

Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens

Kai Rüger et al. J Clin Microbiol. 2014 Jan.

Abstract

Mycobacterium abscessus, which consists of the two subspecies M. abscessus subspecies abscessus and M. abscessus subspecies bolletii, can produce rough or smooth colony morphologies. Here we analyzed 50 M. abscessus isolates cultured from the respiratory specimens of 34 patients, 28 (82%) of whom had cystic fibrosis (CF), with respect to their colony morphologies and antibiotic susceptibilities. The overall proportions of occurrences of the two morphotypes were similar, with specimens from 50% of the patients showing a rough and 38% showing a smooth morphotype. A total of 12% of the specimens from the patients showed both morphotypes simultaneously. At the subspecies level, the proportions of rough and smooth morphotypes differed substantially; 88% of rough morphotypes belonged to M. abscessus subspecies abscessus, and 85% of smooth morphotypes belonged M. abscessus subspecies bolletii. Inducible clarithromycin resistance due to the Erm(41) methylase, as well as high-level resistance to clarithromycin due to mutations within the rrl gene, occurred independently of the morphotype. The MIC50s of amikacin and cefoxitin were identical for the two morphotypes, whereas the MIC50s of tigecycline were 0.25 μg/ml for the rough morphotype and 2.0 μg/ml for the smooth morphotype. Our results show that the smooth morphotype was more dominant in respiratory specimens from CF patients than previously thought. With respect to resistance, colony morphology did not affect the susceptibility of Mycobacterium abscessus to the first-line antibiotics clarithromycin, amikacin, and cefoxitin.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Growth characteristics of rough and smooth phenotypes on 7H11 agar cultured at 37°C: representative single rough (left) and smooth (right) colonies.
FIG 2
FIG 2
Colony morphology of the primary subculture and results of pulsed-field gel electrophoresis of rough and smooth strains from the four patients (P2, P17, P31, and P37) that produced a mixed phenotype. Subcultures from primary specimens that had been kept as frozen stocks were recultured on 7H11 agar at 37°C, and photos were taken. Two patients (P2 and P17) had predominantly rough morphotypes, and two patients (P31 and P37) had predominantly smooth morphotypes. From each patient, one smooth colony and one rough colony were subcultured until the morphotypes remained stable before genomic DNA was prepared, XbaI digested, and separated by pulsed-field gel electrophoresis. The gel photo shows a comparison of the smooth (s) and rough (r) morphotypes from each of the four patients (P2, P17, P31, and P37). M, molecular marker; ATCC, M. abscessus ATCC 19977 type strain.

Similar articles

Cited by

References

    1. Bange FC, Kirschner P, Bottger EC. 1999. Recovery of mycobacteria from patients with cystic fibrosis. J. Clin. Microbiol. 37:3761–3763 - PMC - PubMed
    1. Bange FC, Brown BA, Smaczny C, Wallace RJ, Jr, Bottger EC. 2001. Lack of transmission of Mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. Clin. Infect. Dis. 32:1648–1650. 10.1086/320525 - DOI - PubMed
    1. Bange FC, Bottger EC. 2002. Improved decontamination method for recovering mycobacteria from patients with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 21:546–548. 10.1007/s10096-002-0760-y - DOI - PubMed
    1. Olivier KN, Weber DJ, Wallace RJ, Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, Edwards LJ, Chakraborti S, Knowles MR. 2003. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am. J. Respir. Crit. Care Med. 167:828–834. 10.1164/rccm.200207-678OC - DOI - PubMed
    1. Girón RM, Máiz L, Barrio I, Martínez MT, Salcedo A, Prados C. 2008. Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study. Arch. Bronconeumol. 44:679–684 (In Spanish) 10.1016/S0300-2896(08)75777-6 - DOI - PubMed

Publication types

MeSH terms

Substances